Reach more patients faster with our decentralised clinical trial services
What are decentralised clinical trials and how do they work at Sciensus?
Traditional clinical trials require patients to travel to designated trial sites, which can be a barrier to participation. Decentralised clinical trials remove this obstacle by bringing the trial directly to the patient through remote monitoring, home healthcare visits, and digital data collection. They help to improve:
- Patient recruitment & accessibility – Reaching more diverse and hard-to-reach populations
- Trial retention rates – Reducing dropouts by minimising the burden of travel
- Data quality & compliance – Enabling real-time data collection and patient monitoring
- Cost efficiency – Lowering site-related costs while improving trial scalability
Sciensus is at the forefront of decentralised clinical trials Europe, offering a fully integrated service that makes sure patients receive trial treatments safely and on time, wherever they are.
Sciensus’ unique approach to decentralised clinical trials
We offer an end-to-end clinical trial service, supporting Phase II-IV studies, insight research, and early access schemes. Our experienced clinical trial nurses provide home-based and remote care, improving patient adherence and retention, with many of our supported studies achieving 90%+ retention rates.
- Home & remote patient visits – Nurses administer investigational medicinal products (IMPs), collect samples, and monitor patient safety.
- Remote consent & virtual trial support – Patients can participate from the comfort of their homes using our secure digital platforms.
- Real-time patient engagement & data collection – Advanced digital solutions track adherence and treatment effectiveness.
Direct-to-patient clinical trial support
- Home & remote patient visits – Nurses administer investigational medicinal products (IMPs), collect samples, and monitor patient safety.
- Remote consent & virtual trial support – Patients can participate from the comfort of their homes using our secure digital platforms.
- Real-time patient engagement & data collection – Advanced digital solutions track adherence and treatment effectiveness.
Comprehensive clinical trial logistics
- Temperature-controlled IMP storage & distribution – Handling ambient, refrigerated, frozen, and ultra-low temperatures (-90°C).
- Regulatory-compliant trial management – Covering trial file management, data production, and remote monitoring.
- Integrated pharmacy services – Secure dispensing and supply chain solutions tailored to trial requirements.
Supporting patients on clinical trials. Every step of the way.
o Through our expert pharmacy services, we cover everything from storage, trial file management, randomisation temperature-controlled dispensing and supply from ambient, fridge, frozen and down to -90°C. Our resilient and well-established distribution network covers the whole of Europe, enabling you to widen the geographical reach of your study.
With the latest digital solutions and expertise in other areas such as cash management, data production, remote monitoring and regulatory compliance, we can also help you improve data collection and patient persistence and adherence to protocols.
GDP-compliant distribution
Innovative customisable end-to-end solution
Established European network
Meet our decentralised clinical trials expert
Answering your questions
Are decentralised clinical trials used in the UK?
Yes, decentralised clinical trials are increasingly being adopted in the UK to improve patient recruitment and streamline clinical research. Sciensus has a well-established clinical trial network across the UK and Europe, ensuring seamless execution of remote trials.
What support does Sciensus provide for decentralised trials?
Sciensus offers a full-service decentralised clinical trial solution, including:
- Home-based patient visits by trained nurses
- Regulatory-compliant trial logistics (medication storage, delivery, and monitoring)
- Remote consent & patient engagement platforms
- Real-world data collection for evidence-based insights
How do direct-to-patient clinical trials improve recruitment?
By removing geographical and logistical barriers, direct-to-patient trials make it easier for patients to participate, particularly those in remote or underserved areas. This expands recruitment potential and ensures a more diverse patient population.
How can I partner with Sciensus for decentralised clinical trials?
If you’re looking to integrate decentralised clinical trials in the UK or Europe, Sciensus can help. Contact our expert team today to discuss a tailored solution for your clinical research needs.
Read more on…
News
Sciensus achieves ISO 14001 accreditation
Sciensus is delighted to announce that, after a year of hard work across multiple teams and departments, we have earned…
News
Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities
Sciensus, a leading European life sciences organisation, focused on accelerating patients’ access to lifesaving medicines, is pleased to announce that…
Events
Clinical Pharmacy Congress 2025
Sciensus will be exhibiting at the upcoming Clinical Pharmacy Congress 2025, London, connecting with industry leaders and contributing to the conversation…